Addus HomeCare [ADUS] vs HCA Healthcare [HCA] Detailed Stock Comparison
Addus HomeCare
NASDAQ
Loading...
HCA Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Addus HomeCare wins in 2 metrics, HCA Healthcare wins in 17 metrics, with 0 ties. HCA Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Addus HomeCare | HCA Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.37 | 16.02 | HCA Healthcare |
| Price-to-Book Ratio | 2.06 | -72.79 | HCA Healthcare |
| Debt-to-Equity Ratio | 21.75 | -37.45 | HCA Healthcare |
| PEG Ratio | 19.75 | 15.54 | HCA Healthcare |
| EV/EBITDA | 15.17 | 9.37 | HCA Healthcare |
| Profit Margin (TTM) | 6.51% | 8.21% | HCA Healthcare |
| Operating Margin (TTM) | 9.41% | 15.95% | HCA Healthcare |
| EBITDA Margin (TTM) | 9.41% | 15.95% | HCA Healthcare |
| Return on Equity | 8.54% | 13,631.68% | HCA Healthcare |
| Return on Assets (TTM) | 6.59% | 11.84% | HCA Healthcare |
| Free Cash Flow (TTM) | $110.38M | $5.64B | HCA Healthcare |
| Dividend Yield | N/A | 0.54% | N/A |
| 1-Year Return | -11.63% | 5.74% | HCA Healthcare |
| Price-to-Sales Ratio (TTM) | 1.66 | 1.23 | HCA Healthcare |
| Enterprise Value | $2.24B | $135.84B | HCA Healthcare |
| EV/Revenue Ratio | 1.76 | 1.87 | Addus HomeCare |
| Gross Profit Margin (TTM) | 32.59% | 40.97% | HCA Healthcare |
| Revenue per Share (TTM) | $71 | $292 | HCA Healthcare |
| Earnings per Share (Diluted) | $4.53 | $23.82 | HCA Healthcare |
| Beta (Stock Volatility) | 0.80 | 1.40 | Addus HomeCare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Addus HomeCare vs HCA Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Addus HomeCare | 1.00% | 4.98% | -1.68% | -0.46% | -5.38% | -11.32% |
| HCA Healthcare | 2.22% | 6.90% | 1.06% | 7.82% | 19.91% | 28.16% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Addus HomeCare | -11.63% | 16.65% | 16.27% | 283.73% | 2,273.49% | 1,103.61% |
| HCA Healthcare | 5.74% | 74.34% | 183.87% | 317.52% | 1,126.25% | 1,126.25% |
Performance & Financial Health Analysis: Addus HomeCare vs HCA Healthcare
| Metric | ADUS | HCA |
|---|---|---|
| Market Information | ||
| Market Cap | $2.12B | $89.29B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 197,030 | 1,426,893 |
| 90 Day Avg. Volume | 160,967 | 1,471,124 |
| Last Close | $110.19 | $381.61 |
| 52 Week Range | $88.96 - $136.72 | $289.98 - $417.14 |
| % from 52W High | -19.40% | -8.52% |
| All-Time High | $136.72 (Jan 20, 2025) | $417.14 (Oct 14, 2024) |
| % from All-Time High | -19.40% | -8.52% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.22% | 0.06% |
| Quarterly Earnings Growth | 0.22% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.08% |
| Operating Margin (TTM) | 0.09% | 0.16% |
| Return on Equity (TTM) | 0.09% | 136.32% |
| Debt to Equity (MRQ) | 21.75 | -37.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $55.74 | $-18.61 |
| Cash per Share (MRQ) | $4.97 | $4.45 |
| Operating Cash Flow (TTM) | $100.42M | $11.93B |
| Levered Free Cash Flow (TTM) | $51.48M | $5.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.54% |
| Last 12-Month Dividend | N/A | $2.04 |
Valuation & Enterprise Metrics Analysis: Addus HomeCare vs HCA Healthcare
| Metric | ADUS | HCA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.37 | 16.02 |
| Forward P/E | 19.75 | 15.54 |
| PEG Ratio | 19.75 | 15.54 |
| Price to Sales (TTM) | 1.66 | 1.23 |
| Price to Book (MRQ) | 2.06 | -72.79 |
| Market Capitalization | ||
| Market Capitalization | $2.12B | $89.29B |
| Enterprise Value | $2.24B | $135.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.76 | 1.87 |
| Enterprise to EBITDA | 15.17 | 9.37 |
| Risk & Other Metrics | ||
| Beta | 0.80 | 1.40 |
| Book Value per Share (MRQ) | $55.74 | $-18.61 |
Financial Statements Comparison: Addus HomeCare vs HCA Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ADUS | HCA |
|---|---|---|
| Revenue/Sales | $349.44M | $18.61B |
| Cost of Goods Sold | $235.57M | $10.98B |
| Gross Profit | $113.88M | $7.62B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $32.89M | $2.97B |
| EBITDA | $37.38M | $3.85B |
| Pre-Tax Income | $29.95M | $2.42B |
| Income Tax | $7.89M | $524.00M |
| Net Income (Profit) | $22.05M | $1.89B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ADUS | HCA |
|---|---|---|
| Cash & Equivalents | $96.95M | $1.06B |
| Total Current Assets | $257.83M | $16.26B |
| Total Current Liabilities | $147.94M | $13.63B |
| Long-Term Debt | $238.15M | $42.92B |
| Total Shareholders Equity | $995.38M | $-438.00M |
| Retained Earnings | $397.66M | $-3.16B |
| Property, Plant & Equipment | $69.77M | $65.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ADUS | HCA |
|---|---|---|
| Operating Cash Flow | $16.26M | $2.65B |
| Capital Expenditures | $-1.88M | $-991.00M |
| Free Cash Flow | $17.07M | $660.00M |
| Debt Repayment | $-20.00M | $-3.90B |
| Common Stock Repurchase | N/A | $-2.51B |
Short Interest & Institutional Ownership Analysis
| Metric | ADUS | HCA |
|---|---|---|
| Shares Short | 678,415 | 3.89M |
| Short Ratio | 4.45 | 2.67 |
| Short % of Float | 0.05% | 0.02% |
| Average Daily Volume (10 Day) | 197,030 | 1,426,893 |
| Average Daily Volume (90 Day) | 160,967 | 1,471,124 |
| Shares Outstanding | 18.15M | 249.98M |
| Float Shares | 17.48M | 161.55M |
| % Held by Insiders | 0.03% | 0.31% |
| % Held by Institutions | 1.03% | 0.68% |
Dividend Analysis & Yield Comparison: Addus HomeCare vs HCA Healthcare
| Metric | ADUS | HCA |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.04 |
| Last 12-Month Dividend Yield | N/A | 0.54% |
| 3-Year Avg Annual Dividend | N/A | $2.29 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $6.88 |
| Ex-Dividend Date | N/A | Mar 17, 2025 |